½ÃÀ庸°í¼­
»óǰÄÚµå
1585638

»ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Biological Safety Cabinet Market by Type (Class I, Class II, Class III), End User (Academic & Research Organizations, Diagnostics & Testing Laboratories, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀº 2023³â¿¡ 4¾ï 5,646¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 4¾ï 9,474¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.47%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 8¾ï 693¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

BSC´Â º´¿ø¼º ¹Ì»ý¹°·ÎºÎÅÍ »ç¿ëÀÚ¿Í È¯°æÀ» º¸È£Çϱâ À§ÇØ ¼³°èµÈ ¹ÐÆóµÇ°í ȯ±âµÈ ½ÇÇè½Ç ÀÛ¾÷ °ø°£À¸·Î, »ý¹° ÀÇÇÐ, Á¦¾à ¹× »ý¸í°øÇÐ ¿¬±¸¿¡ Àû¿ëµÇ°í ÀÖÀ¸¸ç, BSCÀÇ Çʿ伺Àº ½ÇÇè½Ç, »ê¾÷ ȯ°æ ¹× ÀÇ·á ½Ã¼³¿¡¼­ »ý¹°ÇÐÀû ¾ÈÀü º¸Àå ¹× ¿À¿° ¹æÁö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¹× ¿À¿° ¹æÁö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÔÀ¸·Î½á BSCÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¿¬±¸±â°ü°ú ÀÓ»ó ½ÇÇè½Ç¿¡¼­ º´¿ø°ú Á¦¾àȸ»ç¿¡ À̸£±â±îÁö ±× ¿ëµµ¿Í ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ±¤¹üÀ§Çϸç, Äڷγª19¿Í °°Àº ¼¼°è º¸°Ç À§Çù ¼Ó¿¡¼­ ¾ö°ÝÇÑ ¾ÈÀü ±âÁØÀÇ Çʿ伺ÀÌ ´ëµÎµÇ¸é¼­ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÇÇè Á¾»çÀÚ ¾ÈÀü¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© µîÀÌ ÀÖ½À´Ï´Ù. °³¼±µÈ °ø±â È帧 ½Ã½ºÅÛ ¹× ÷´Ü ¿©°ú ±â¼ú°ú °°Àº ±â¼ú ¹ßÀüÀº ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ R&D ¹× ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÇÔ²² ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë, º¹ÀâÇÑ À¯Áöº¸¼ö ¿ä°Ç, ±ä ±ÔÁ¦ ±â°ü ½ÂÀÎ ÀýÂ÷ µîÀÇ ¹®Á¦·Î ÀÎÇØ ¼Ò±Ô¸ð ¿¬±¸¼Ò°¡ BSC¸¦ µµÀÔÇÏ´Â °ÍÀ» ÁÖÀúÇÒ ¼ö ÀÖ´Ù´Â Á¡Àº ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ¸ðµ¨ °³¹ß, µðÁöÅÐ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ÅëÇÕ, ¼³°è ¹× Á¦Á¶¿¡¼­ ģȯ°æ ¼ÒÀç Ž»ö°ú °°Àº Çõ½Å ºÎ¹®¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¬±¸ ±â°ü°úÀÇ Á¦ÈÞ ¹× Çù·ÂÀ» ÃËÁøÇÏ¿© Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» ÃßÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº ¿Ï¸¸Çϸç, ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷µéÀº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ À¯ÁöÇϰí ÁøÈ­ÇÏ´Â ¾ÈÀü Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ²÷ÀÓ¾øÀÌ Çõ½ÅÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. »ç¾÷ ¼ºÀåÀ» ¿øÇÏ´Â ±â¾÷Àº źźÇÑ R&D Àü·«¿¡ ÅõÀÚÇϰí, ½ÅÈï ½ÃÀåÀ» °³Ã´Çϰí, ƯÁ¤ ¿¬±¸¼ÒÀÇ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÏ´Â ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸ Áß½ÉÀÇ Çõ½Å Á¢±Ù ¹æ½ÄÀº ±âÁ¸ ½ÃÀå °úÁ¦¸¦ ±Øº¹ÇÏ°í ¹ÙÀÌ¿À ¾ÈÀü ijºñ´Ö¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 4¾ï 5,646¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 4¾ï 9,474¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 8¾ï 693¸¸ ´Þ·¯
CAGR(%) 8.47%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®À» °ø°³ÇÕ´Ï´Ù.

»ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÇ·á »ê¾÷¿¡¼­ »ý¹° ¾ÈÀü ijºñ´ÖÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â À¯¸®ÇÑ ±ÔÁ¦
    • À¯Ç༺ Áúº´ ¹× Àü¿°º´ À§Çè Áõ°¡
    • »ý¹°ÇÐÀû Á¦Á¦ ¼ö ±ÞÁõ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ´ëü º¸°ü ijºñ´Ö
  • ½ÃÀå ±âȸ
    • ¹ÙÀÌ¿ÀÀǾàǰ ¹× Á¦¾à±â¾÷ÀÇ ¿¬±¸°³¹ß Ȱµ¿ Áõ°¡
    • »ý¹°ÇÐÀû Á¦Á¦ ¼öÀÇ ±Þ°ÝÇÑ Áõ°¡ ¼ºÀå±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë
  • ½ÃÀå °úÁ¦
    • Àúºñ¿ë °íǰÁú »ý¹° ¾ÈÀü ijºñ´Ö °³¹ß

Porter's Five Forces : »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» º¸¿ÏÇϰí, ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

»ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, À̸¦ ÅëÇØ °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå¿¡¼­ º¥´õÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

»ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ, ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • Class I
  • Class II
    • Class II Type A
    • Class II Type B
  • Class III

Á¦7Àå »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • Çмú±â°ü ¹× ¿¬±¸±â°ü
  • Áø´Ü ¹× °Ë»ç ¿¬±¸¼Ò
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ý¹° ¾ÈÀü ijºñ´Ö ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Air Science USA LLC by PyroGenesis Canada Inc.
  • Alpha Linear
  • Berner International GmbH
  • Biobase Biodusty(Shandong), Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone S.p.A.
  • Flow Sciences, Inc.
  • Germfree Laboratories, Inc.
  • Haier Biomedical
  • Kewaunee Scientific Corporation
  • Labconco Corporation
  • Stericox India Private Limited
  • The Baker Company
  • Thermo Fisher Scientific Inc.
  • TopAir Systems Inc.
LSH

The Biological Safety Cabinet Market was valued at USD 456.46 million in 2023, expected to reach USD 494.74 million in 2024, and is projected to grow at a CAGR of 8.47%, to USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is an enclosed, ventilated lab workspace designed to protect both the user and the environment from pathogenic microorganisms, with applications spanning biomedical, pharmaceutical, and biotechnological research. The necessity of BSCs is underscored by their critical role in ensuring biosafety and preventing contamination in laboratories, industrial settings, and healthcare facilities. The application and end-use scope are vast, extending from research institutions and clinical laboratories to hospitals and pharmaceutical companies, with increasing adoption driven by the need for stringent safety standards amid global health threats like COVID-19. Significant growth factors influencing the BSC market include the rise of infectious diseases, escalating biosecurity concerns, and stringent regulatory frameworks regarding laboratory personnel safety. Technological advancements, such as improved airflow systems and advanced filtration technologies, offer potential growth opportunities, along with increased investment in R&D and healthcare infrastructure, particularly in emerging markets. However, market growth faces challenges such as high initial costs, complex maintenance requirements, and a lengthy approval process from regulatory bodies, which may deter small-scale labs from adopting BSCs. To capitalize on emerging opportunities, companies can focus on areas of innovation, such as developing energy-efficient models, integrating digital monitoring systems, and exploring eco-friendly materials in design and manufacturing. Encouraging partnerships and collaborations with research institutions can also drive forward innovative solutions. The market presents a moderately competitive landscape with key players consistently innovating to maintain market presence and comply with evolving safety standards. Enterprises aiming for business growth should invest in robust R&D strategies, tap into emerging markets, and offer customization to meet specific lab requirements. This research-centered innovation approach could help in overcoming the existing market challenges and cater to the growing biosafety cabinet demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 456.46 million
Estimated Year [2024] USD 494.74 million
Forecast Year [2030] USD 806.93 million
CAGR (%) 8.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Cabinet Market

The Biological Safety Cabinet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • Increased risk of pandemics and communicable diseases
    • Rapid growth in the number of biologics
  • Market Restraints
    • Alternative containment cabinet
  • Market Opportunities
    • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • Market Challenges
    • Development of low cost high quality biological safety cabinets

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Cabinet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Cabinet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Cabinet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Cabinet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Cabinet Market

A detailed market share analysis in the Biological Safety Cabinet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Cabinet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Cabinet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Cabinet Market

A strategic analysis of the Biological Safety Cabinet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Class I, Class II, and Class III. The Class II is further studied across Class II Type A and Class II Type B.
  • Based on End User, market is studied across Academic & Research Organizations, Diagnostics & Testing Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
      • 5.1.1.2. Increased risk of pandemics and communicable diseases
      • 5.1.1.3. Rapid growth in the number of biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Alternative containment cabinet
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
      • 5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Development of low cost high quality biological safety cabinets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Safety Cabinet Market, by Type

  • 6.1. Introduction
  • 6.2. Class I
  • 6.3. Class II
    • 6.3.1. Class II Type A
    • 6.3.2. Class II Type B
  • 6.4. Class III

7. Biological Safety Cabinet Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Organizations
  • 7.3. Diagnostics & Testing Laboratories
  • 7.4. Pharmaceutical & Biopharmaceutical Companies

8. Americas Biological Safety Cabinet Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biological Safety Cabinet Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biological Safety Cabinet Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Science USA LLC by PyroGenesis Canada Inc.
  • 2. Alpha Linear
  • 3. Berner International GmbH
  • 4. Biobase Biodusty (Shandong), Co., Ltd.
  • 5. Esco Micro Pte. Ltd.
  • 6. EuroClone S.p.A.
  • 7. Flow Sciences, Inc.
  • 8. Germfree Laboratories, Inc.
  • 9. Haier Biomedical
  • 10. Kewaunee Scientific Corporation
  • 11. Labconco Corporation
  • 12. Stericox India Private Limited
  • 13. The Baker Company
  • 14. Thermo Fisher Scientific Inc.
  • 15. TopAir Systems Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦